Global Hydrogel Drug Delivery Systems Market

Hydrogel Drug Delivery Systems Comprehensive Study by Application (Healthcare, Hygiene, Contact Lenses, Tissue Engineering, Others), Composition (Silicon Hydrogel, Polyacrylate, Polyacrylamide), Hydrogels (Synthetic Hydrogels, Natural Hydrogels, Hybrid Hydrogels) Players and Region - Global Market Outlook to 2027

Hydrogel Drug Delivery Systems Market by XX Submarkets | Forecast Years 2022-2027  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
About Hydrogel Drug Delivery Systems
Hydrogels have an extensive vary of biomedical functions different than drug transport such as manufacturing contact lenses, wound dressings, and tissue engineering. The mechanism of drug transport by means of the usage of hydrogel entails diffusion-based drug launch from the hydrogel mesh or pores crammed with water. This reservoir shipping machine ensures time-independent and regular drug release. Different hydrogel merchandise are administered through more than a few routes of administration such as peroral, rectal, ocular, and transdermal amongst others. The hydrogel structures have various therapeutic functions such as for treating inflammatory diseases, cardiac sickness & cancer, and diabetic foot ulcer amongst others.

AttributesDetails
Study Period2017-2027
Base Year2021
UnitValue (USD Million)


Clinical trials using hydrogel drug delivery system structures have proven promising results, motivating pharmaceutical corporations to make investments in such therapeutic strategies. According to a 2019 NCBI report, the hydrogel was once employed in 223 medical trials for medicinal or diagnostic purposes, aside from contact lens trials. In the 223 medical trials, the hydrogel coil used to be employed in eight of them, the bulk hydrogel in 166, and the patch hydrogel in 99. Analyst at AMA Research estimates that United States Players will contribute the maximum growth to Global Hydrogel Drug Delivery Systems market throughout the forecasted period. Established and emerging Players should take a closer view at their existing organizations and reinvent traditional business and operating models to adapt to the future.

Ashland (United States), Bausch and Lomb (Canada), Johnson & Johnson (United States), Micropore Technologies (United Kingdom), Medtronic (Ireland), Neurelis, Inc., (United States), Ocular Therapeutix, Inc, (United States), ProLynx Inc., (United States), Pfizer, Inc., (United States) and Teva Pharmaceutical Industries Ltd. (Israel) are some of the key players that are part of study coverage.

Segmentation Overview
AMA Research has segmented the market of Global Hydrogel Drug Delivery Systems market by , Application (Healthcare, Hygiene, Contact Lenses, Tissue Engineering and Others) and Region.



On the basis of geography, the market of Hydrogel Drug Delivery Systems has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). If we see Market by Composition, the sub-segment i.e. Silicon Hydrogel will boost the Hydrogel Drug Delivery Systems market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by Hydrogels, the sub-segment i.e. Synthetic Hydrogels will boost the Hydrogel Drug Delivery Systems market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.

Hydrogel Drug Delivery Systems Market Dynamics:
AttributesDetails
Growth Drivers
  • Increased Investment and Expenditure in R&D Operation
Influencing Trends
  • Rising Adoption of Hydrogel in Ocular Delivery
Restraints
  • Compatibility Issues with Some of the Medicines
  • High Cost of Hydrogels
Road Blocks / Challenges
  • Supply Chain Disruptions
  • Increasing Approval of New Hydrogel-Based Products
Gaps & Opportunities
  • Growing Investment and Funding By Leading Pharma Companies in R&D Activities In Search Of A New Drug, Delivery Systems, And Diagnostic


In 2020, Bausch + Lomb, a main international eye fitness commercial enterprise of Bausch Health Companies, has launched the Bausch + Lomb INFUSETM silicone hydrogel each day disposable contact lens. It is the first silicone hydrogel every day disposable with a fabric infused with science named ProBalance to enhance ocular floor homeostasis and alleviate signs of contact lens dryness, which influences about 1/2 of the forty five Mn lens customers in the U.S.
the U.S. Food and Drug Administration approved Plenity manufactured by Gelesis a biotechnology company for the treatment of obesity. Plenity is a non-systemic, oral formulation made up of super absorbent hydrogel which is used for weight management in adults. The capsule works by inducing a feeling of fullness so that individuals eat less and eventually aid in losing weight.

Key Target Audience
Hydrogen Drug Delivery System Providers, Government Regulations, Venture Capitalists and Others

About Approach
To evaluate and validate the market size various sources including primary and secondary analysis is utilized. AMA Research follows regulatory standards such as NAICS/SIC/ICB/TRCB, to have a better understanding of the market. The market study is conducted on basis of more than 200 companies dealing in the market regional as well as global areas with the purpose to understand the companies positioning regarding the market value, volume, and their market share for regional as well as global.

Further to bring relevance specific to any niche market we set and apply a number of criteria like Geographic Footprints, Regional Segments of Revenue, Operational Centres, etc. The next step is to finalize a team (In-House + Data Agencies) who then starts collecting C & D level executives and profiles, Industry experts, Opinion leaders, etc., and work towards appointment generation.

The primary research is performed by taking the interviews of executives of various companies dealing in the market as well as using the survey reports, research institute, and latest research reports. Meanwhile, the analyst team keeps preparing a set of questionnaires, and after getting the appointee list; the target audience is then tapped and segregated with various mediums and channels that are feasible for making connections that including email communication, telephonic, skype, LinkedIn Group & InMail, Community Forums, Community Forums, open Survey, SurveyMonkey, etc.

Report Objectives / Segmentation Covered

By Application
  • Healthcare
  • Hygiene
  • Contact Lenses
  • Tissue Engineering
  • Others
By Composition
  • Silicon Hydrogel
  • Polyacrylate
  • Polyacrylamide

By Hydrogels
  • Synthetic Hydrogels
  • Natural Hydrogels
  • Hybrid Hydrogels

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Increased Investment and Expenditure in R&D Operation
    • 3.3. Market Challenges
      • 3.3.1. Supply Chain Disruptions
      • 3.3.2. Increasing Approval of New Hydrogel-Based Products
    • 3.4. Market Trends
      • 3.4.1. Rising Adoption of Hydrogel in Ocular Delivery
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Hydrogel Drug Delivery Systems, by Application, Composition, Hydrogels and Region (value) (2016-2021)
    • 5.1. Introduction
    • 5.2. Global Hydrogel Drug Delivery Systems (Value)
      • 5.2.1. Global Hydrogel Drug Delivery Systems by: Application (Value)
        • 5.2.1.1. Healthcare
        • 5.2.1.2. Hygiene
        • 5.2.1.3. Contact Lenses
        • 5.2.1.4. Tissue Engineering
        • 5.2.1.5. Others
      • 5.2.2. Global Hydrogel Drug Delivery Systems by: Composition (Value)
        • 5.2.2.1. Silicon Hydrogel
        • 5.2.2.2. Polyacrylate
        • 5.2.2.3. Polyacrylamide
      • 5.2.3. Global Hydrogel Drug Delivery Systems Region
        • 5.2.3.1. South America
          • 5.2.3.1.1. Brazil
          • 5.2.3.1.2. Argentina
          • 5.2.3.1.3. Rest of South America
        • 5.2.3.2. Asia Pacific
          • 5.2.3.2.1. China
          • 5.2.3.2.2. Japan
          • 5.2.3.2.3. India
          • 5.2.3.2.4. South Korea
          • 5.2.3.2.5. Taiwan
          • 5.2.3.2.6. Australia
          • 5.2.3.2.7. Rest of Asia-Pacific
        • 5.2.3.3. Europe
          • 5.2.3.3.1. Germany
          • 5.2.3.3.2. France
          • 5.2.3.3.3. Italy
          • 5.2.3.3.4. United Kingdom
          • 5.2.3.3.5. Netherlands
          • 5.2.3.3.6. Rest of Europe
        • 5.2.3.4. MEA
          • 5.2.3.4.1. Middle East
          • 5.2.3.4.2. Africa
        • 5.2.3.5. North America
          • 5.2.3.5.1. United States
          • 5.2.3.5.2. Canada
          • 5.2.3.5.3. Mexico
  • 6. Hydrogel Drug Delivery Systems: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2021)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Ashland (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Bausch and Lomb (Canada)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Johnson & Johnson (United States)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Micropore Technologies (United Kingdom)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Medtronic (Ireland)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Neurelis, Inc., (United States)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Ocular Therapeutix, Inc, (United States)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. ProLynx Inc., (United States)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Pfizer, Inc., (United States)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Teva Pharmaceutical Industries Ltd. (Israel)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
  • 7. Global Hydrogel Drug Delivery Systems Sale, by Application, Composition, Hydrogels and Region (value) (2022-2027)
    • 7.1. Introduction
    • 7.2. Global Hydrogel Drug Delivery Systems (Value)
      • 7.2.1. Global Hydrogel Drug Delivery Systems by: Application (Value)
        • 7.2.1.1. Healthcare
        • 7.2.1.2. Hygiene
        • 7.2.1.3. Contact Lenses
        • 7.2.1.4. Tissue Engineering
        • 7.2.1.5. Others
      • 7.2.2. Global Hydrogel Drug Delivery Systems by: Composition (Value)
        • 7.2.2.1. Silicon Hydrogel
        • 7.2.2.2. Polyacrylate
        • 7.2.2.3. Polyacrylamide
      • 7.2.3. Global Hydrogel Drug Delivery Systems Region
        • 7.2.3.1. South America
          • 7.2.3.1.1. Brazil
          • 7.2.3.1.2. Argentina
          • 7.2.3.1.3. Rest of South America
        • 7.2.3.2. Asia Pacific
          • 7.2.3.2.1. China
          • 7.2.3.2.2. Japan
          • 7.2.3.2.3. India
          • 7.2.3.2.4. South Korea
          • 7.2.3.2.5. Taiwan
          • 7.2.3.2.6. Australia
          • 7.2.3.2.7. Rest of Asia-Pacific
        • 7.2.3.3. Europe
          • 7.2.3.3.1. Germany
          • 7.2.3.3.2. France
          • 7.2.3.3.3. Italy
          • 7.2.3.3.4. United Kingdom
          • 7.2.3.3.5. Netherlands
          • 7.2.3.3.6. Rest of Europe
        • 7.2.3.4. MEA
          • 7.2.3.4.1. Middle East
          • 7.2.3.4.2. Africa
        • 7.2.3.5. North America
          • 7.2.3.5.1. United States
          • 7.2.3.5.2. Canada
          • 7.2.3.5.3. Mexico
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Hydrogel Drug Delivery Systems: by Application(USD Million)
  • Table 2. Hydrogel Drug Delivery Systems Healthcare , by Region USD Million (2016-2021)
  • Table 3. Hydrogel Drug Delivery Systems Hygiene , by Region USD Million (2016-2021)
  • Table 4. Hydrogel Drug Delivery Systems Contact Lenses , by Region USD Million (2016-2021)
  • Table 5. Hydrogel Drug Delivery Systems Tissue Engineering , by Region USD Million (2016-2021)
  • Table 6. Hydrogel Drug Delivery Systems Others , by Region USD Million (2016-2021)
  • Table 7. Hydrogel Drug Delivery Systems: by Composition(USD Million)
  • Table 8. Hydrogel Drug Delivery Systems Silicon Hydrogel , by Region USD Million (2016-2021)
  • Table 9. Hydrogel Drug Delivery Systems Polyacrylate , by Region USD Million (2016-2021)
  • Table 10. Hydrogel Drug Delivery Systems Polyacrylamide , by Region USD Million (2016-2021)
  • Table 11. South America Hydrogel Drug Delivery Systems, by Country USD Million (2016-2021)
  • Table 12. South America Hydrogel Drug Delivery Systems, by Application USD Million (2016-2021)
  • Table 13. South America Hydrogel Drug Delivery Systems, by Composition USD Million (2016-2021)
  • Table 14. South America Hydrogel Drug Delivery Systems, by Hydrogels USD Million (2016-2021)
  • Table 15. Brazil Hydrogel Drug Delivery Systems, by Application USD Million (2016-2021)
  • Table 16. Brazil Hydrogel Drug Delivery Systems, by Composition USD Million (2016-2021)
  • Table 17. Brazil Hydrogel Drug Delivery Systems, by Hydrogels USD Million (2016-2021)
  • Table 18. Argentina Hydrogel Drug Delivery Systems, by Application USD Million (2016-2021)
  • Table 19. Argentina Hydrogel Drug Delivery Systems, by Composition USD Million (2016-2021)
  • Table 20. Argentina Hydrogel Drug Delivery Systems, by Hydrogels USD Million (2016-2021)
  • Table 21. Rest of South America Hydrogel Drug Delivery Systems, by Application USD Million (2016-2021)
  • Table 22. Rest of South America Hydrogel Drug Delivery Systems, by Composition USD Million (2016-2021)
  • Table 23. Rest of South America Hydrogel Drug Delivery Systems, by Hydrogels USD Million (2016-2021)
  • Table 24. Asia Pacific Hydrogel Drug Delivery Systems, by Country USD Million (2016-2021)
  • Table 25. Asia Pacific Hydrogel Drug Delivery Systems, by Application USD Million (2016-2021)
  • Table 26. Asia Pacific Hydrogel Drug Delivery Systems, by Composition USD Million (2016-2021)
  • Table 27. Asia Pacific Hydrogel Drug Delivery Systems, by Hydrogels USD Million (2016-2021)
  • Table 28. China Hydrogel Drug Delivery Systems, by Application USD Million (2016-2021)
  • Table 29. China Hydrogel Drug Delivery Systems, by Composition USD Million (2016-2021)
  • Table 30. China Hydrogel Drug Delivery Systems, by Hydrogels USD Million (2016-2021)
  • Table 31. Japan Hydrogel Drug Delivery Systems, by Application USD Million (2016-2021)
  • Table 32. Japan Hydrogel Drug Delivery Systems, by Composition USD Million (2016-2021)
  • Table 33. Japan Hydrogel Drug Delivery Systems, by Hydrogels USD Million (2016-2021)
  • Table 34. India Hydrogel Drug Delivery Systems, by Application USD Million (2016-2021)
  • Table 35. India Hydrogel Drug Delivery Systems, by Composition USD Million (2016-2021)
  • Table 36. India Hydrogel Drug Delivery Systems, by Hydrogels USD Million (2016-2021)
  • Table 37. South Korea Hydrogel Drug Delivery Systems, by Application USD Million (2016-2021)
  • Table 38. South Korea Hydrogel Drug Delivery Systems, by Composition USD Million (2016-2021)
  • Table 39. South Korea Hydrogel Drug Delivery Systems, by Hydrogels USD Million (2016-2021)
  • Table 40. Taiwan Hydrogel Drug Delivery Systems, by Application USD Million (2016-2021)
  • Table 41. Taiwan Hydrogel Drug Delivery Systems, by Composition USD Million (2016-2021)
  • Table 42. Taiwan Hydrogel Drug Delivery Systems, by Hydrogels USD Million (2016-2021)
  • Table 43. Australia Hydrogel Drug Delivery Systems, by Application USD Million (2016-2021)
  • Table 44. Australia Hydrogel Drug Delivery Systems, by Composition USD Million (2016-2021)
  • Table 45. Australia Hydrogel Drug Delivery Systems, by Hydrogels USD Million (2016-2021)
  • Table 46. Rest of Asia-Pacific Hydrogel Drug Delivery Systems, by Application USD Million (2016-2021)
  • Table 47. Rest of Asia-Pacific Hydrogel Drug Delivery Systems, by Composition USD Million (2016-2021)
  • Table 48. Rest of Asia-Pacific Hydrogel Drug Delivery Systems, by Hydrogels USD Million (2016-2021)
  • Table 49. Europe Hydrogel Drug Delivery Systems, by Country USD Million (2016-2021)
  • Table 50. Europe Hydrogel Drug Delivery Systems, by Application USD Million (2016-2021)
  • Table 51. Europe Hydrogel Drug Delivery Systems, by Composition USD Million (2016-2021)
  • Table 52. Europe Hydrogel Drug Delivery Systems, by Hydrogels USD Million (2016-2021)
  • Table 53. Germany Hydrogel Drug Delivery Systems, by Application USD Million (2016-2021)
  • Table 54. Germany Hydrogel Drug Delivery Systems, by Composition USD Million (2016-2021)
  • Table 55. Germany Hydrogel Drug Delivery Systems, by Hydrogels USD Million (2016-2021)
  • Table 56. France Hydrogel Drug Delivery Systems, by Application USD Million (2016-2021)
  • Table 57. France Hydrogel Drug Delivery Systems, by Composition USD Million (2016-2021)
  • Table 58. France Hydrogel Drug Delivery Systems, by Hydrogels USD Million (2016-2021)
  • Table 59. Italy Hydrogel Drug Delivery Systems, by Application USD Million (2016-2021)
  • Table 60. Italy Hydrogel Drug Delivery Systems, by Composition USD Million (2016-2021)
  • Table 61. Italy Hydrogel Drug Delivery Systems, by Hydrogels USD Million (2016-2021)
  • Table 62. United Kingdom Hydrogel Drug Delivery Systems, by Application USD Million (2016-2021)
  • Table 63. United Kingdom Hydrogel Drug Delivery Systems, by Composition USD Million (2016-2021)
  • Table 64. United Kingdom Hydrogel Drug Delivery Systems, by Hydrogels USD Million (2016-2021)
  • Table 65. Netherlands Hydrogel Drug Delivery Systems, by Application USD Million (2016-2021)
  • Table 66. Netherlands Hydrogel Drug Delivery Systems, by Composition USD Million (2016-2021)
  • Table 67. Netherlands Hydrogel Drug Delivery Systems, by Hydrogels USD Million (2016-2021)
  • Table 68. Rest of Europe Hydrogel Drug Delivery Systems, by Application USD Million (2016-2021)
  • Table 69. Rest of Europe Hydrogel Drug Delivery Systems, by Composition USD Million (2016-2021)
  • Table 70. Rest of Europe Hydrogel Drug Delivery Systems, by Hydrogels USD Million (2016-2021)
  • Table 71. MEA Hydrogel Drug Delivery Systems, by Country USD Million (2016-2021)
  • Table 72. MEA Hydrogel Drug Delivery Systems, by Application USD Million (2016-2021)
  • Table 73. MEA Hydrogel Drug Delivery Systems, by Composition USD Million (2016-2021)
  • Table 74. MEA Hydrogel Drug Delivery Systems, by Hydrogels USD Million (2016-2021)
  • Table 75. Middle East Hydrogel Drug Delivery Systems, by Application USD Million (2016-2021)
  • Table 76. Middle East Hydrogel Drug Delivery Systems, by Composition USD Million (2016-2021)
  • Table 77. Middle East Hydrogel Drug Delivery Systems, by Hydrogels USD Million (2016-2021)
  • Table 78. Africa Hydrogel Drug Delivery Systems, by Application USD Million (2016-2021)
  • Table 79. Africa Hydrogel Drug Delivery Systems, by Composition USD Million (2016-2021)
  • Table 80. Africa Hydrogel Drug Delivery Systems, by Hydrogels USD Million (2016-2021)
  • Table 81. North America Hydrogel Drug Delivery Systems, by Country USD Million (2016-2021)
  • Table 82. North America Hydrogel Drug Delivery Systems, by Application USD Million (2016-2021)
  • Table 83. North America Hydrogel Drug Delivery Systems, by Composition USD Million (2016-2021)
  • Table 84. North America Hydrogel Drug Delivery Systems, by Hydrogels USD Million (2016-2021)
  • Table 85. United States Hydrogel Drug Delivery Systems, by Application USD Million (2016-2021)
  • Table 86. United States Hydrogel Drug Delivery Systems, by Composition USD Million (2016-2021)
  • Table 87. United States Hydrogel Drug Delivery Systems, by Hydrogels USD Million (2016-2021)
  • Table 88. Canada Hydrogel Drug Delivery Systems, by Application USD Million (2016-2021)
  • Table 89. Canada Hydrogel Drug Delivery Systems, by Composition USD Million (2016-2021)
  • Table 90. Canada Hydrogel Drug Delivery Systems, by Hydrogels USD Million (2016-2021)
  • Table 91. Mexico Hydrogel Drug Delivery Systems, by Application USD Million (2016-2021)
  • Table 92. Mexico Hydrogel Drug Delivery Systems, by Composition USD Million (2016-2021)
  • Table 93. Mexico Hydrogel Drug Delivery Systems, by Hydrogels USD Million (2016-2021)
  • Table 94. Company Basic Information, Sales Area and Its Competitors
  • Table 95. Company Basic Information, Sales Area and Its Competitors
  • Table 96. Company Basic Information, Sales Area and Its Competitors
  • Table 97. Company Basic Information, Sales Area and Its Competitors
  • Table 98. Company Basic Information, Sales Area and Its Competitors
  • Table 99. Company Basic Information, Sales Area and Its Competitors
  • Table 100. Company Basic Information, Sales Area and Its Competitors
  • Table 101. Company Basic Information, Sales Area and Its Competitors
  • Table 102. Company Basic Information, Sales Area and Its Competitors
  • Table 103. Company Basic Information, Sales Area and Its Competitors
  • Table 104. Hydrogel Drug Delivery Systems: by Application(USD Million)
  • Table 105. Hydrogel Drug Delivery Systems Healthcare , by Region USD Million (2022-2027)
  • Table 106. Hydrogel Drug Delivery Systems Hygiene , by Region USD Million (2022-2027)
  • Table 107. Hydrogel Drug Delivery Systems Contact Lenses , by Region USD Million (2022-2027)
  • Table 108. Hydrogel Drug Delivery Systems Tissue Engineering , by Region USD Million (2022-2027)
  • Table 109. Hydrogel Drug Delivery Systems Others , by Region USD Million (2022-2027)
  • Table 110. Hydrogel Drug Delivery Systems: by Composition(USD Million)
  • Table 111. Hydrogel Drug Delivery Systems Silicon Hydrogel , by Region USD Million (2022-2027)
  • Table 112. Hydrogel Drug Delivery Systems Polyacrylate , by Region USD Million (2022-2027)
  • Table 113. Hydrogel Drug Delivery Systems Polyacrylamide , by Region USD Million (2022-2027)
  • Table 114. South America Hydrogel Drug Delivery Systems, by Country USD Million (2022-2027)
  • Table 115. South America Hydrogel Drug Delivery Systems, by Application USD Million (2022-2027)
  • Table 116. South America Hydrogel Drug Delivery Systems, by Composition USD Million (2022-2027)
  • Table 117. South America Hydrogel Drug Delivery Systems, by Hydrogels USD Million (2022-2027)
  • Table 118. Brazil Hydrogel Drug Delivery Systems, by Application USD Million (2022-2027)
  • Table 119. Brazil Hydrogel Drug Delivery Systems, by Composition USD Million (2022-2027)
  • Table 120. Brazil Hydrogel Drug Delivery Systems, by Hydrogels USD Million (2022-2027)
  • Table 121. Argentina Hydrogel Drug Delivery Systems, by Application USD Million (2022-2027)
  • Table 122. Argentina Hydrogel Drug Delivery Systems, by Composition USD Million (2022-2027)
  • Table 123. Argentina Hydrogel Drug Delivery Systems, by Hydrogels USD Million (2022-2027)
  • Table 124. Rest of South America Hydrogel Drug Delivery Systems, by Application USD Million (2022-2027)
  • Table 125. Rest of South America Hydrogel Drug Delivery Systems, by Composition USD Million (2022-2027)
  • Table 126. Rest of South America Hydrogel Drug Delivery Systems, by Hydrogels USD Million (2022-2027)
  • Table 127. Asia Pacific Hydrogel Drug Delivery Systems, by Country USD Million (2022-2027)
  • Table 128. Asia Pacific Hydrogel Drug Delivery Systems, by Application USD Million (2022-2027)
  • Table 129. Asia Pacific Hydrogel Drug Delivery Systems, by Composition USD Million (2022-2027)
  • Table 130. Asia Pacific Hydrogel Drug Delivery Systems, by Hydrogels USD Million (2022-2027)
  • Table 131. China Hydrogel Drug Delivery Systems, by Application USD Million (2022-2027)
  • Table 132. China Hydrogel Drug Delivery Systems, by Composition USD Million (2022-2027)
  • Table 133. China Hydrogel Drug Delivery Systems, by Hydrogels USD Million (2022-2027)
  • Table 134. Japan Hydrogel Drug Delivery Systems, by Application USD Million (2022-2027)
  • Table 135. Japan Hydrogel Drug Delivery Systems, by Composition USD Million (2022-2027)
  • Table 136. Japan Hydrogel Drug Delivery Systems, by Hydrogels USD Million (2022-2027)
  • Table 137. India Hydrogel Drug Delivery Systems, by Application USD Million (2022-2027)
  • Table 138. India Hydrogel Drug Delivery Systems, by Composition USD Million (2022-2027)
  • Table 139. India Hydrogel Drug Delivery Systems, by Hydrogels USD Million (2022-2027)
  • Table 140. South Korea Hydrogel Drug Delivery Systems, by Application USD Million (2022-2027)
  • Table 141. South Korea Hydrogel Drug Delivery Systems, by Composition USD Million (2022-2027)
  • Table 142. South Korea Hydrogel Drug Delivery Systems, by Hydrogels USD Million (2022-2027)
  • Table 143. Taiwan Hydrogel Drug Delivery Systems, by Application USD Million (2022-2027)
  • Table 144. Taiwan Hydrogel Drug Delivery Systems, by Composition USD Million (2022-2027)
  • Table 145. Taiwan Hydrogel Drug Delivery Systems, by Hydrogels USD Million (2022-2027)
  • Table 146. Australia Hydrogel Drug Delivery Systems, by Application USD Million (2022-2027)
  • Table 147. Australia Hydrogel Drug Delivery Systems, by Composition USD Million (2022-2027)
  • Table 148. Australia Hydrogel Drug Delivery Systems, by Hydrogels USD Million (2022-2027)
  • Table 149. Rest of Asia-Pacific Hydrogel Drug Delivery Systems, by Application USD Million (2022-2027)
  • Table 150. Rest of Asia-Pacific Hydrogel Drug Delivery Systems, by Composition USD Million (2022-2027)
  • Table 151. Rest of Asia-Pacific Hydrogel Drug Delivery Systems, by Hydrogels USD Million (2022-2027)
  • Table 152. Europe Hydrogel Drug Delivery Systems, by Country USD Million (2022-2027)
  • Table 153. Europe Hydrogel Drug Delivery Systems, by Application USD Million (2022-2027)
  • Table 154. Europe Hydrogel Drug Delivery Systems, by Composition USD Million (2022-2027)
  • Table 155. Europe Hydrogel Drug Delivery Systems, by Hydrogels USD Million (2022-2027)
  • Table 156. Germany Hydrogel Drug Delivery Systems, by Application USD Million (2022-2027)
  • Table 157. Germany Hydrogel Drug Delivery Systems, by Composition USD Million (2022-2027)
  • Table 158. Germany Hydrogel Drug Delivery Systems, by Hydrogels USD Million (2022-2027)
  • Table 159. France Hydrogel Drug Delivery Systems, by Application USD Million (2022-2027)
  • Table 160. France Hydrogel Drug Delivery Systems, by Composition USD Million (2022-2027)
  • Table 161. France Hydrogel Drug Delivery Systems, by Hydrogels USD Million (2022-2027)
  • Table 162. Italy Hydrogel Drug Delivery Systems, by Application USD Million (2022-2027)
  • Table 163. Italy Hydrogel Drug Delivery Systems, by Composition USD Million (2022-2027)
  • Table 164. Italy Hydrogel Drug Delivery Systems, by Hydrogels USD Million (2022-2027)
  • Table 165. United Kingdom Hydrogel Drug Delivery Systems, by Application USD Million (2022-2027)
  • Table 166. United Kingdom Hydrogel Drug Delivery Systems, by Composition USD Million (2022-2027)
  • Table 167. United Kingdom Hydrogel Drug Delivery Systems, by Hydrogels USD Million (2022-2027)
  • Table 168. Netherlands Hydrogel Drug Delivery Systems, by Application USD Million (2022-2027)
  • Table 169. Netherlands Hydrogel Drug Delivery Systems, by Composition USD Million (2022-2027)
  • Table 170. Netherlands Hydrogel Drug Delivery Systems, by Hydrogels USD Million (2022-2027)
  • Table 171. Rest of Europe Hydrogel Drug Delivery Systems, by Application USD Million (2022-2027)
  • Table 172. Rest of Europe Hydrogel Drug Delivery Systems, by Composition USD Million (2022-2027)
  • Table 173. Rest of Europe Hydrogel Drug Delivery Systems, by Hydrogels USD Million (2022-2027)
  • Table 174. MEA Hydrogel Drug Delivery Systems, by Country USD Million (2022-2027)
  • Table 175. MEA Hydrogel Drug Delivery Systems, by Application USD Million (2022-2027)
  • Table 176. MEA Hydrogel Drug Delivery Systems, by Composition USD Million (2022-2027)
  • Table 177. MEA Hydrogel Drug Delivery Systems, by Hydrogels USD Million (2022-2027)
  • Table 178. Middle East Hydrogel Drug Delivery Systems, by Application USD Million (2022-2027)
  • Table 179. Middle East Hydrogel Drug Delivery Systems, by Composition USD Million (2022-2027)
  • Table 180. Middle East Hydrogel Drug Delivery Systems, by Hydrogels USD Million (2022-2027)
  • Table 181. Africa Hydrogel Drug Delivery Systems, by Application USD Million (2022-2027)
  • Table 182. Africa Hydrogel Drug Delivery Systems, by Composition USD Million (2022-2027)
  • Table 183. Africa Hydrogel Drug Delivery Systems, by Hydrogels USD Million (2022-2027)
  • Table 184. North America Hydrogel Drug Delivery Systems, by Country USD Million (2022-2027)
  • Table 185. North America Hydrogel Drug Delivery Systems, by Application USD Million (2022-2027)
  • Table 186. North America Hydrogel Drug Delivery Systems, by Composition USD Million (2022-2027)
  • Table 187. North America Hydrogel Drug Delivery Systems, by Hydrogels USD Million (2022-2027)
  • Table 188. United States Hydrogel Drug Delivery Systems, by Application USD Million (2022-2027)
  • Table 189. United States Hydrogel Drug Delivery Systems, by Composition USD Million (2022-2027)
  • Table 190. United States Hydrogel Drug Delivery Systems, by Hydrogels USD Million (2022-2027)
  • Table 191. Canada Hydrogel Drug Delivery Systems, by Application USD Million (2022-2027)
  • Table 192. Canada Hydrogel Drug Delivery Systems, by Composition USD Million (2022-2027)
  • Table 193. Canada Hydrogel Drug Delivery Systems, by Hydrogels USD Million (2022-2027)
  • Table 194. Mexico Hydrogel Drug Delivery Systems, by Application USD Million (2022-2027)
  • Table 195. Mexico Hydrogel Drug Delivery Systems, by Composition USD Million (2022-2027)
  • Table 196. Mexico Hydrogel Drug Delivery Systems, by Hydrogels USD Million (2022-2027)
  • Table 197. Research Programs/Design for This Report
  • Table 198. Key Data Information from Secondary Sources
  • Table 199. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Hydrogel Drug Delivery Systems: by Application USD Million (2016-2021)
  • Figure 5. Global Hydrogel Drug Delivery Systems: by Composition USD Million (2016-2021)
  • Figure 6. South America Hydrogel Drug Delivery Systems Share (%), by Country
  • Figure 7. Asia Pacific Hydrogel Drug Delivery Systems Share (%), by Country
  • Figure 8. Europe Hydrogel Drug Delivery Systems Share (%), by Country
  • Figure 9. MEA Hydrogel Drug Delivery Systems Share (%), by Country
  • Figure 10. North America Hydrogel Drug Delivery Systems Share (%), by Country
  • Figure 11. Global Hydrogel Drug Delivery Systems share by Players 2021 (%)
  • Figure 12. Global Hydrogel Drug Delivery Systems share by Players (Top 3) 2021(%)
  • Figure 13. Global Hydrogel Drug Delivery Systems share by Players (Top 5) 2021(%)
  • Figure 14. BCG Matrix for key Companies
  • Figure 15. Ashland (United States) Revenue, Net Income and Gross profit
  • Figure 16. Ashland (United States) Revenue: by Geography 2021
  • Figure 17. Bausch and Lomb (Canada) Revenue, Net Income and Gross profit
  • Figure 18. Bausch and Lomb (Canada) Revenue: by Geography 2021
  • Figure 19. Johnson & Johnson (United States) Revenue, Net Income and Gross profit
  • Figure 20. Johnson & Johnson (United States) Revenue: by Geography 2021
  • Figure 21. Micropore Technologies (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 22. Micropore Technologies (United Kingdom) Revenue: by Geography 2021
  • Figure 23. Medtronic (Ireland) Revenue, Net Income and Gross profit
  • Figure 24. Medtronic (Ireland) Revenue: by Geography 2021
  • Figure 25. Neurelis, Inc., (United States) Revenue, Net Income and Gross profit
  • Figure 26. Neurelis, Inc., (United States) Revenue: by Geography 2021
  • Figure 27. Ocular Therapeutix, Inc, (United States) Revenue, Net Income and Gross profit
  • Figure 28. Ocular Therapeutix, Inc, (United States) Revenue: by Geography 2021
  • Figure 29. ProLynx Inc., (United States) Revenue, Net Income and Gross profit
  • Figure 30. ProLynx Inc., (United States) Revenue: by Geography 2021
  • Figure 31. Pfizer, Inc., (United States) Revenue, Net Income and Gross profit
  • Figure 32. Pfizer, Inc., (United States) Revenue: by Geography 2021
  • Figure 33. Teva Pharmaceutical Industries Ltd. (Israel) Revenue, Net Income and Gross profit
  • Figure 34. Teva Pharmaceutical Industries Ltd. (Israel) Revenue: by Geography 2021
  • Figure 35. Global Hydrogel Drug Delivery Systems: by Application USD Million (2022-2027)
  • Figure 36. Global Hydrogel Drug Delivery Systems: by Composition USD Million (2022-2027)
  • Figure 37. South America Hydrogel Drug Delivery Systems Share (%), by Country
  • Figure 38. Asia Pacific Hydrogel Drug Delivery Systems Share (%), by Country
  • Figure 39. Europe Hydrogel Drug Delivery Systems Share (%), by Country
  • Figure 40. MEA Hydrogel Drug Delivery Systems Share (%), by Country
  • Figure 41. North America Hydrogel Drug Delivery Systems Share (%), by Country
List of companies from research coverage that are profiled in the study
  • Ashland (United States)
  • Bausch and Lomb (Canada)
  • Johnson & Johnson (United States)
  • Micropore Technologies (United Kingdom)
  • Medtronic (Ireland)
  • Neurelis, Inc., (United States)
  • Ocular Therapeutix, Inc, (United States)
  • ProLynx Inc., (United States)
  • Pfizer, Inc., (United States)
  • Teva Pharmaceutical Industries Ltd. (Israel)
Select User Access Type

Key Highlights of Report


Aug 2022 222 Pages 64 Tables Base Year: 2021 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Hydrogel Drug Delivery Systems Market Quantitative research analysis
Global Hydrogel Drug Delivery Systems Market Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

The standard version of the report profiles players such as Ashland (United States), Bausch and Lomb (Canada), Johnson & Johnson (United States), Micropore Technologies (United Kingdom), Medtronic (Ireland), Neurelis, Inc., (United States), Ocular Therapeutix, Inc, (United States), ProLynx Inc., (United States), Pfizer, Inc., (United States) and Teva Pharmaceutical Industries Ltd. (Israel) etc.
The Study can be customized subject to feasibility and data availability. Please connect with our sales representative for further information.
"Rising Adoption of Hydrogel in Ocular Delivery" is seen as one of major influencing trends for Hydrogel Drug Delivery Systems Market during projected period 2021-2027.
The Hydrogel Drug Delivery Systems market study includes a random mix of players, including both market leaders and some top growing emerging players. Connect with our sales executive to get a complete company list in our research coverage.

Know More About Global Hydrogel Drug Delivery Systems Market Report?

Have a Query? Click Here

Other Related Reports

Dog Cloning- Comprehensive Study by Type (Gene Cloning, Reproductive Cloning, Therapeutic Cloning), Application (Companion Dogs, Service Dogs, Others), Species (Endangered Species, Extinct Species) P...
$ 3800
Reproductive Genetics Comprehensive Study by Type (Laboratory Developed Tests (LDT), Kits, Reagents and Consumables), Application (Aneuploidy, Single Gene Disorders, Structural Abnormalities, Others)...
$ 3800
Smart Aquaculture Systems Comprehensive Study by Application (Fish, Crab, Shrimp, Others), System (Closed System, Open System), Aquaculture (Marine, Freshwater) Players and Region - Global Market Out...
$ 3500
Insect Biotechnology Comprehensive Study by Application (Biochemical Recycling, Pollination, Biological Control, Pest Management, Gene Therapy, Other), Technique (Recombinant DNA Technology, Transgen...
$ 3800
microRNA Based Diagnostic Kit Comprehensive Study by Mode of Delivery (Conjugation, Virus-Associated Delivery, Nanoparticles), End Use (Hospitals and Clinics, Diagnostic Laboratories, Academic & Gove...
$ 3800
Azadirachtin- Comprehensive Study by Application (Insecticides, Nematicides, Pesticides, Other), BY form (Liquid, Powder), BY End Use (Agriculture, Animal Husbandry, Horticulture, Cosmetics, Food & ...
$ 3800